Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Cardlytics, Inc. (CDLX)

Cardlytics Q2 revenue falls 36% to $36.9 million; net loss widens to $14.9 million

Negative Impact 4 of 5 earnings Written later

Cardlytics reported second quarter 2026 revenue of $36.9 million, down 36% from a year earlier, and a net loss of $14.9 million, up from $9.3 million. Its third quarter revenue forecast of $34.0 million to $39.0 million also implies a year-over-year decline of 17% to 27%, so shareholders face continued pressure on the top line.

Key points

  • Q2 2026 revenue was $36.9 million, down from $58.0 million in Q2 2025; billings were $65.5 million, down 34%.
  • Net loss was $14.9 million versus $9.3 million a year earlier; GAAP loss per share from continuing operations was $(1.50) versus $(1.15).
  • Adjusted EBITDA was $1.7 million, compared with $3.0 million in Q2 2025.
  • Q3 2026 guidance: revenue of $34.0 million to $39.0 million and billings of $61.0 million to $67.0 million; Bridg business sold March 24, 2026.

The filing

CompanyCardlytics, Inc. (CDLX)
Form8-K, current report
Filed with the SECAug 5, 2026, 4:02 PM ET
Accession number0001628280-26-053285

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.